Biogen (NASDAQ:BIIB) reported quarterly earnings results on February 06, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $1.99,…
Biogen (NASDAQ:BIIB) reported quarterly earnings results on February 06, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.99, beating the consensus estimate of $1.62 by $0.37 per share. Revenue came in at $2.3B, beating the estimate of $2.2B.
Biogen's stock moved following the earnings release. The stock currently trades at $196.50 with a market capitalization of $25.3B.
Current market data
NASDAQ · BIIB
$218.50
Up: +$0.05 · +0.02%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
